- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 16-12-2025: Press Release
16-12-2025 | 03:34 pm
16-12-2025 | 03:34 pm
Glenmark's subsidiary secured exclusive multi-regional rights for Aumolertinib from Hansoh Pharma, boosting its oncology pipeline for lung cancer. The deal includes a low double-digit million USD upfront payment, plus potential milestones over US$1 billion and tiered royalties.
No comments yet. Be the first to comment!